These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22157056)

  • 1. Lymphoscintigraphy revealed abnormal lymphatic drainage in chyloperitoneum.
    Yoshimura M
    Clin Nucl Med; 2012 Jan; 37(1):e7-e10. PubMed ID: 22157056
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoscintigraphy in a patient with polyserositis of unknown origin.
    Prior JO; Boubaker A; Spertini F; Delaloye AB
    Clin Nucl Med; 2002 Dec; 27(12):905-6. PubMed ID: 12607880
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax.
    Pui MH; Yueh TC
    J Nucl Med; 1998 Jul; 39(7):1292-6. PubMed ID: 9669413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pelvic lymphoscintigraphy to demonstrate lymphoid fluid leakage in an ovarian cancer patient with chylous ascites.
    Tu DG; Yao WJ; Chen YH; Hwang SM
    Kaohsiung J Med Sci; 2008 Mar; 24(3):163-6. PubMed ID: 18364278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoscintigraphy for interpretation of changes of cervical lymph node function in patients with oral malignant tumors: comparison of Tc-99m-Re and Tc-99m-HSA-D.
    Sato T; Yamaguchi K; Morita Y; Noikura T; Sugihara K; Matsune S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):525-37. PubMed ID: 11027392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized mammary lymphoscintigraphy using larger colloid particles.
    Mirzaei S; Knoll P; Hoffmann B; Kreuzer W; Kohn H
    J Nucl Med; 2001 May; 42(5):826. PubMed ID: 11337584
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
    Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
    J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of lymphoscintigraphy with a new technetium compound for metastatic cervical lymphadenopathy.
    Sato T; Morita Y; Kawabata Y; Noikura T; Yamaguchi K; Sugihara K; Matsune S
    Dentomaxillofac Radiol; 2000 Jul; 29(4):230-7. PubMed ID: 10918456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is preoperative lymphoscintigraphy for sentinel node in cervical cancer required?
    Bats AS; Lavoué V; Barranger E; Daraï E
    Am J Obstet Gynecol; 2007 Jul; 197(1):116. PubMed ID: 17618788
    [No Abstract]   [Full Text] [Related]  

  • 10. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.
    Bedrosian I; Scheff AM; Mick R; Callans LS; Bucky LP; Spitz FR; Helsabeck C; Elder DE; Alavi A; Fraker DF; Czerniecki BJ
    J Nucl Med; 1999 Jul; 40(7):1143-8. PubMed ID: 10405134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer with chylous ascites demonstrated by lymphoscintigraphy: successful treatment with peritoneovenous shunting.
    Wagayama H; Tanaka T; Shimomura M; Ogura K; Shiraki K
    Dig Dis Sci; 2002 Aug; 47(8):1836-8. PubMed ID: 12184538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide lymphangioscintigraphy in the evaluation of peripheral lymphedema.
    Williams WH; Witte CL; Witte MH; McNeill GC
    Clin Nucl Med; 2000 Jun; 25(6):451-64. PubMed ID: 10836695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of Tc-99m HIG and Tc-99m nanocolloid on sentinel lymph node mapping in patients with breast cancer.
    Yalçin H; Gençoglu EA; Yagmurdur M; Aras M; Ozen A; Aktas A
    Nucl Med Commun; 2010 Oct; 31(10):903-9. PubMed ID: 20683362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can lymphoscintigraphy and gamma probe method in sentinel node biopsy for differentiated thyroid carcinoma obviate the disadvantages of the blue-dye method?
    Peparini N; Di Matteo FM; Tartaglia F; Maturo A
    Eur J Surg Oncol; 2007 Aug; 33(6):815-6. PubMed ID: 17218076
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
    Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
    Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periareolar injections and hot sentinel nodes.
    Kim CK; Krynyckyi BR; Machac J; Pelosi E; Bisi G
    J Nucl Med; 2004 Sep; 45(9):1597-9; author reply 1599. PubMed ID: 15347731
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
    Rasgon BM
    Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoscintigraphy pre- and post-surgical lymphatic leak repair.
    Andrews JT; Binder LJ
    Australas Radiol; 1996 Feb; 40(1):19-21. PubMed ID: 8838882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
    Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
    Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.